GlaxoSmithKline Consumer Nigeria PLC 1 Industrial Avenue, Ilupeju

RC 8726 PMB 21218 Ikeja, Lagos

Tel: +234 (01) 2711000, (01) 3242900 www.gsk.com/ng

Lagos, 31st March 2023

NOTICE OF SCHEDULED BOARD MEETING

This is to notify the General Public and the Exchange, that the Board of Directors' meeting of GlaxoSmithKline Consumer Nigeria Plc (the Company) scheduled to hold on Thursday, 30th March 2023 held as scheduled and the Board of directors approved:

1. The Audited Financial Statements of GlaxoSmithKline Consumer Nigeria Plc for the Year Ended 31st December 2022

The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons earlier announced will terminate 24 hours after the release of the approved Audited Financial Statements to the Market.

For: GlaxoSmithKline Consumer Nigeria PLC

Frederick Ichekwai

Company Secretary

Agbara Factory: Km 32, Igbesa Road, Agbara, Ogun State. Tel: +234 (01) 2918000.Email: Customer_ch_nigeria@gsk.com

Directors: Mr. Edmund Onuzo, Chairman; Mr. Kunle Oyelana, Managing Director; Mr. Samuel Kuye; Mr. Bosco Kirugi (Kenyan) Finance Director,

Mrs. Oludewa Edodo-Thorpe; D. Ms. Amina Salihu

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Glaxo Smithkline Consumer Nigeria plc published this content on 31 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2023 12:04:05 UTC.